💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for GlycoMimetics, Inc. (GLYC)
« Back to company indexGLYC Chatter Timeline
Stock Ticker for GLYC
Most Active Tweeters for GLYC
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @PennySearch | 6 |
| @TradingChromat1 | 4 |
| @InsiderAlerts4U | 4 |
| @lqqkerinsider | 4 |
Recent Tweets for GLYC
 |
@YouCanFoolMost RT @Tickeron: How does this affect your portfolio? $GLYC Aroon Indicator entered a Downtrend. #GlycoMimetics #stockmarket #stock https://t.… 4:01am |
 |
@Tickeron How does this affect your portfolio? $GLYC Aroon Indicator entered a Downtrend. #GlycoMimetics #stockmarket #stock… https://t.co/btjFy1ezZD 4:01am |
 |
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP Finance, CFO BRIAN M. HAHN: https://t.co/FDIfAIscMU 4:01am |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP of Research, CSO JOHN L. MAGNANI: https://t.co/wiFGnYUDzd 3:01am |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's Chief Executive Officer HAROUT SEMERJIAN: https://t.co/6x18SLGJMa 2:01am |
 |
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: Chief Executive Officer Semerjian Harout: Transacted Derivative Securities… https://t.co/FjNEL9bt48 2:01am |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP Finance, CFO Hahn Brian M.: Transacted Derivative Securities between 20… https://t.co/phXZMVDjmt 2:01am |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP, Chief Business Officer ARMAND GIRARD: https://t.co/zcZ9Ugc6It 2:01am |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP of Research, CSO Magnani John L.: Transacted Derivative Securities betw… https://t.co/8mDzDon44w 2:01am |
 |
@lqqkerinsider $GLYC Just putting it out there. But if you need to raise ? or are just really nervous, I've got a 50k share orde… https://t.co/hLlZaIHRuX January 25th 2022, 2:01pm |
|
@lqqkerinsider $GLYC Taking a stab at the basis for our new play word, <<< ARCHERY >>> ? ? ? ? ? ? ? https://t.co/NHAkvjoHmQ https://t.co/Q5pFAHVXtf January 25th 2022, 2:01am |
|
@lqqkerinsider $GLYC Who can spot the main difference between the Jan 2022 Investor Presention (on left) and the Nov 2021 version… https://t.co/a85IEL1wtU January 25th 2022, 12:01am |
 |
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/kc47aX7X0z January 24th 2022, 6:01pm |
 |
@TradingChromat1 Awaiting Buy signal on $GLYC https://t.co/Lgmfkheszv January 24th 2022, 3:01pm |
 |
@trademarktrader ARCHERY is in the process of being trademarked by Glycomimetics, Inc. https://t.co/0aDjZastK1 #ARCHERY $GLYC $BLK https://t.co/OX4ADM2B1e January 24th 2022, 6:01am |
|
@lqqkerinsider $GLYC Well, January ended up being trash for just about everybody and everything. And while GlycoMimetics also per… https://t.co/ObbhjA9h9A January 24th 2022, 12:01am |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/T8W8ON5iTY January 23rd 2022, 12:01am |
|
@Tickeron $GLYC's Aroon indicator drops into Downtrend on January 20, 2022. View odds for this and other indicators:… https://t.co/GI8kDqQcwG January 21st 2022, 10:01pm |
|
@Tickeron How do you think the market will react to this? $GLYC Aroon Indicator entered a Downtrend. #GlycoMimetics… https://t.co/pZEKoZnZXI January 21st 2022, 9:01pm |
 |
@Gambiste1 RT @biosleuth: I know $GLYC has ben completely dumped, but there is a highly asymmetric opportunity for this niche of biology to take off.… January 21st 2022, 8:01pm |
 |
@biosleuth I know $GLYC has ben completely dumped, but there is a highly asymmetric opportunity for this niche of biology to t… https://t.co/aSQ1i9hZrW January 21st 2022, 8:01pm |
 |
@sanjeevredkar Checkout GlycoMimetics $GLYC Founder John Magnani and his team has been in Glycobiology therapeutics over the past… https://t.co/CT7e4SUzrV January 21st 2022, 2:01pm |
 |
@MaiteMerenda $GLYC Bullish pattern forming. Chart by https://t.co/t5kOjgtuCB https://t.co/sWkIogDwV5 January 20th 2022, 6:01pm |
 |
@A1Syad $GLYC Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/huO578SOXO January 20th 2022, 1:01pm |
|
@TradingChromat1 Awaiting Buy signal on $GLYC https://t.co/An2WXwWY26 January 19th 2022, 11:01pm |
 |
@Ba4Saso $GLYC Bullish pattern building. Chart by https://t.co/z6vAd7dl0q https://t.co/CbT7sdf7p7 January 18th 2022, 7:01pm |
|
@Tickeron $GLYC enters a Downtrend because Momentum Indicator dropped below the 0 level on December 21, 2021. View odds for t… https://t.co/KhEx1ozFVx January 18th 2022, 3:01pm |
|
@TradingChromat1 Awaiting Buy signal on $GLYC https://t.co/7PvFsH39uP January 17th 2022, 7:01pm |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/fNMVLpag0i January 17th 2022, 2:01pm |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/jfFmgnx4q8 January 16th 2022, 9:01pm |
 |
@StckPro $GLYC NEW ARTICLE : GlycoMimetics: Great Upside, Great Risks for this Biotech Stock https://t.co/m0Mnl3k1uX Get all… https://t.co/3NNxhBrqui January 16th 2022, 12:01pm |
|
@Tickeron $GLYC enters a Downtrend because Momentum Indicator dropped below the 0 level on December 21, 2021. View odds for t… https://t.co/8U7jet3W7M January 14th 2022, 2:01am |
|
@Tickeron If you’re trading this week, Read This! $GLYC Aroon Indicator entered a Downtrend. #GlycoMimetics #stockmarket… https://t.co/2gDlzK9DOI January 14th 2022, 1:01am |
|
@Tickeron How will this affect the market? $GLYC RSI Indicator left the oversold zone. #GlycoMimetics #stockmarket #stock… https://t.co/91oOl1rBS0 January 13th 2022, 10:01pm |
 |
@ShortAlgoTrades $GLYC Almost ripe for a jump! Chart by https://t.co/jpmUt7BvVp https://t.co/RwR7NT85cg January 13th 2022, 9:01pm |
|
@MaiteMerenda $GLYC Awaiting Buy Signal. Free Trial at https://t.co/t5kOjgsWN3 https://t.co/e4JgvahQ8I January 13th 2022, 2:01pm |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/9oz9hp3lzf January 13th 2022, 8:01am |
|
@TradingChromat1 Awaiting Buy signal on $GLYC https://t.co/7DbBMRcXdK January 12th 2022, 6:01pm |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/8IQIA8eGls January 12th 2022, 2:01pm |
|
@lqqkerinsider $GLYC FYI: LQQKER noticed U today. https://t.co/vqbxVOaYo1 January 11th 2022, 10:01pm |
|
@ShortAlgoTrades $GLYC Almost ripe for a run Chart by https://t.co/jpmUt7BvVp https://t.co/bYw1Dfv43M January 11th 2022, 4:01pm |
|
@lqqkerinsider $GLYC WHY... https://t.co/ZZYe7Yyt0Q January 11th 2022, 3:01pm |
|
@ShortAlgoTrades $GLYC Awaiting Buy Signal. Chart by https://t.co/jpmUt7BvVp https://t.co/jKYVCaADRe January 11th 2022, 1:01pm |
|
@Tickeron $GLYC's Aroon indicator drops into Downtrend on January 7, 2022. View odds for this and other indicators:… https://t.co/UeEpbT58V3 January 11th 2022, 3:01am |
|
@lqqkerinsider $GLYC How will GlycoMimetics raise capital in 2022/2023? NOTE: Only select ATM if you believe it will be the only method used. January 11th 2022, 12:01am |
|
@TradingChromat1 Awaiting Buy signal on $GLYC https://t.co/WxnVcLBxy1 January 10th 2022, 4:01pm |
 |
@kwhenfinance GlycoMimetics Inc Shares Near 52-Week Low - Market Mover https://t.co/kDbt7iMRSX $GLYC #stockmarket #kwhenfinance January 10th 2022, 6:01am |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/yHWzQu23qe January 9th 2022, 7:01pm |
|
@ShortAlgoTrades $GLYC Waiting for Buy Signal. Chart by https://t.co/jpmUt7BvVp https://t.co/aY3t5RA7jK January 8th 2022, 1:01pm |
|
@PennySearch $GLYC Jefferies gave GLYC a Buy stock rating on 2021-11-12. Find top penny stocks with PennySearch before the mo… https://t.co/whk4xLbM9Y January 6th 2022, 10:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?